[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 83
Citations 0
September 26, 2012

Treatment of Sepsis-Related Organ Dysfunction—Reply

Author Affiliations

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliations: Department of Pneumology, Medizinische Hochschule Hannover, Hannover, Germany (Dr Welte; welte.tobias@mh-hannover.de); Department of Anesthesiology and Intensive Care Medicine, Friedrich-Schiller University, Jena, Germany (Dr Brunkhorst); and Clinical Trial Center Leipzig, University of Leipzig, Leipzig, Germany (Ms Kuhnt).

JAMA. 2012;308(12):1206-1207. doi:10.1001/2012.jama.11271

In Reply: Both Dr Rodríguez-Baño and Dr Du and colleagues raise similar concerns that the treatment options of meropenem monotherapy vs meropenem plus moxifloxacin used in our study appear to contradict current guidelines for the treatment of severe community-acquired pneumonia, which recommend a combination of a β-lactam and a macrolide or an antipseudomonal β-lactam combined with an aminoglycoside or ciprofloxacin in cases of suspected Pseudomonas infection.1 While we agree with these recommendations for treating pneumonia, our study focused on patients with severe sepsis and septic shock independent of the focus of infection.

First Page Preview View Large
First page PDF preview
First page PDF preview